Condition: ST Elevation Myocardial Infarction (STEMI) · Sponsor: Institute of Cardiovascular Diseases, Vojvodina
The objective of the study is to compare drug-coated balloon (DCB) with the gold standard drug-eluting stent (DES) in percutaneous coronary intervention (PCI) for patients presenting with ST-elevation myocardial infarction (STEMI). Randomization will be performed after successful culprit-lesion preparation and confirmation that all angiographic entry criteria are met. Patients will be randomly assigned in a 1:1 fashion to receive either treatment with a Paclitaxel-coated balloon alone or second or third-generation DES.
This description comes directly from the study's public registry record.
Mila Kovačević, MD, PhD · +381601594444 · milakov979@gmail.com
Branislav Crnomarković, MD · +381642636495 · branislavc.89@gmail.com
Always discuss trial participation with your own doctor first.
| University Clinical Centre of the Republic of Srpska | Banja Luka, Bosnia and Herzegovina | Recruiting |
| University Clinical Centre of Nis | Niš, Serbia, Serbia | Not Yet Recruiting |
| University Clinical Center of Serbia | Belgrade, Serbia | Recruiting |
| Institute of Cardiovascular Diseases of Vojvodina | Kamenitz, Serbia | Recruiting |
| University Clinical Center of Kragujevac | Kragujevac, Serbia | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06746233